The human amniotic membrane derived MSC secretome restrains neuroinflammation and peripheral immune cell invasion of 3D neural tissue through conserved CXCL10 blockade and proteostatic rescue

The human brain is a fortress, protected by a specialized barrier that keeps most of the body's immune system out. This arrangement is vital for keeping delicate nerve cells safe, but it creates a difficult problem when the brain becomes inflamed. In many conditions that cause memory loss or movement disorders, the brain's own defense cells become overactive and start damaging healthy tissue. At the same time, signals from the brain can sometimes call in outside immune cells from the blood, which then cross the barrier and add to the chaos. Finding a way to calm this internal fire without shutting down the brain's necessary defenses or letting the outside invaders in has been a major challenge for scientists. They are looking for treatments that can act like a precise thermostat, turning down the heat of inflammation while leaving the essential functions of the brain untouched.

A team of researchers has investigated a potential solution derived from a biological source that is usually discarded after birth: the lining of the amniotic sac. They studied the liquid secreted by cells taken from this membrane, a mixture rich in proteins and signaling molecules. Rather than using the cells themselves, the team focused on this "secretome," the cocktail of substances the cells release, which can be applied to tissues without the risks of transplanting living cells. Their goal was to see if this liquid could calm the specific type of inflammation that damages the brain, and to understand exactly how it works. They built a series of increasingly complex models to test this, starting with simple layers of human cells and moving up to tiny, three-dimensional spheres of brain tissue that mimic the real organ's structure.

The researchers began by growing human cells that act like neurons, astrocytes, and microglia, the three main types of cells in the brain. They exposed these cells to inflammatory triggers that mimic a brain under attack. In this state, the cells typically start producing harmful signals and begin to die. When the team added the amniotic secretome, the behavior of the cells changed dramatically. The secretome stopped the cells from producing many of the dangerous signals that drive inflammation and cell death. Crucially, it did not just silence the cells; it actively encouraged them to produce signals associated with healthy brain function, such as those needed for nerve connections to form and strengthen. The treatment was selective: it turned down the noise of inflammation while keeping the music of normal brain activity playing.

To see if this effect held up in a more realistic setting, the scientists created three-dimensional spheres of brain tissue containing all three cell types working together. When these spheres were inflamed, they released a flood of chemical signals that would normally attract immune cells from the blood. The researchers found that the amniotic secretome stopped this flood. It reduced the release of every inflammatory signal they measured. Interestingly, the secretome also caused a slight physical change to the outer layers of these tissue spheres, a process driven by natural enzymes that break down proteins. However, this did not kill the cells; the tissue remained healthy and alive. The key finding was that the secretome successfully calmed the internal environment of the brain tissue without causing any damage to the cells themselves.

The next step was to see if this calm environment actually stopped outside immune cells from invading. The team set up an experiment where they placed human blood cells above the inflamed brain tissue spheres. Normally, the chemical signals from the inflamed tissue would act like a beacon, pulling the blood cells down into the brain tissue. When the brain tissue was treated with the amniotic secretome, this beacon was dimmed. The blood cells stopped migrating toward the tissue. But the effect was not a blanket blockage; the secretome was highly specific. It stopped the migration of a particular type of helper immune cell that is often responsible for driving autoimmune damage, while leaving the migration of other immune cells, such as those that fight infections, largely unaffected. This suggests the treatment could protect the brain from autoimmune attacks without leaving it defenseless against real infections.

To understand the molecular mechanics behind this protection, the researchers used a model made from mouse stem cells that formed brain tissue without any immune cells present. This allowed them to see the direct effect of the secretome on brain cells alone. They discovered that the treatment stopped the formation of "stress granules," which are clumps of proteins that build up inside cells when they are under severe stress and can lead to cell death. By preventing these clumps from forming, the secretome kept the brain cells functioning normally even when they were under inflammatory attack. Detailed analysis of the genes and proteins in these cells confirmed that the treatment turned off pathways related to cell death and stress, while turning on pathways that help cells survive.

Across all these different models, one specific protein signal stood out as the primary target of the treatment. This protein, known as CXCL10, is a major chemical messenger that calls immune cells into the brain. The researchers found that the amniotic secretome consistently and strongly reduced the amount of this protein, even at very low concentrations. Because this protein is a known driver of the immune cell invasion seen in diseases like multiple sclerosis, its suppression provides a clear explanation for why the treatment worked. The study suggests that by blocking this single signal, the secretome prevents the cascade of events that leads to immune cells entering the brain and causing damage.

The work confirms that the secretome from human amniotic membrane cells acts as a precise regulator of brain inflammation. It does not simply shut down the immune system or kill the cells that are causing the problem. Instead, it selectively dampens the specific signals that recruit harmful immune cells and stops the internal stress that leads to cell death, all while preserving the brain's ability to function and defend itself against other threats. The findings offer a promising, cell-free approach to treating neuroinflammation, relying on the natural healing properties of a substance that is already available and safe for human use.